Chimerix Analyst Ratings
Chimerix Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/16/2023 | 1057.89% | HC Wainwright & Co. | $11 → $11 | Reiterates | Buy → Buy |
| 08/04/2023 | 1057.89% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 05/23/2023 | 636.84% | Baird | → $7 | Initiates Coverage On | → Outperform |
| 05/05/2023 | 1057.89% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 03/03/2023 | 1057.89% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 09/07/2022 | 636.84% | Capital One | → $7 | Initiates Coverage On | → Overweight |
| 05/17/2022 | 1057.89% | HC Wainwright & Co. | $24 → $11 | Maintains | Buy |
| 12/22/2021 | 2426.32% | HC Wainwright & Co. | $21 → $24 | Maintains | Buy |
| 11/22/2021 | 2110.53% | HC Wainwright & Co. | $19 → $21 | Maintains | Buy |
| 06/07/2021 | 1900% | HC Wainwright & Co. | $18 → $19 | Maintains | Buy |
| 05/06/2021 | 1794.74% | HC Wainwright & Co. | $16 → $18 | Maintains | Buy |
| 04/29/2021 | 2005.26% | Maxim Group | → $20 | Initiates Coverage On | → Buy |
| 03/31/2021 | 2110.53% | Jefferies | → $21 | Initiates Coverage On | → Buy |
| 03/31/2021 | 1373.68% | Wedbush | → $14 | Initiates Coverage On | → Outperform |
| 01/11/2021 | 1584.21% | HC Wainwright & Co. | $7 → $16 | Maintains | Buy |
| 03/06/2019 | 110.53% | Citigroup | $4.25 → $2 | Maintains | Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/16/2023 | 1057.89% | HC Wainwright公司 | $11→$11 | 重申 | 購買→購買 |
| 08/04/2023 | 1057.89% | HC Wainwright公司 | →$11 | 重申 | 購買→購買 |
| 2023年05月23日 | 636.84% | 貝爾德 | →$7 | 開始承保 | →跑贏大盤 |
| 05/05/2023 | 1057.89% | HC Wainwright公司 | →$11 | 重申 | →購買 |
| 03/03/2023 | 1057.89% | HC Wainwright公司 | →$11 | 重申 | →購買 |
| 09/07/2022 | 636.84% | 大寫一 | →$7 | 開始承保 | →超重 |
| 2022/05/17 | 1057.89% | HC Wainwright公司 | $24→$11 | 維護 | 買 |
| 2021年12月22日 | 2426.32% | HC Wainwright公司 | $21→$24 | 維護 | 買 |
| 2021年11月22日 | 2110.53% | HC Wainwright公司 | $19→$21 | 維護 | 買 |
| 06/07/2021 | 1900% | HC Wainwright公司 | $18→$19 | 維護 | 買 |
| 05/06/2021 | 1794.74% | HC Wainwright公司 | $16→$18 | 維護 | 買 |
| 04/29/2021 | 2005.26% | Maxim集團 | →$20 | 開始承保 | →購買 |
| 03/31/2021 | 2110.53% | 傑富瑞 | →$21 | 開始承保 | →購買 |
| 03/31/2021 | 1373.68% | 韋德布什 | →$14 | 開始承保 | →跑贏大盤 |
| 2021/11/01 | 1584.21% | HC Wainwright公司 | $7→$16 | 維護 | 買 |
| 2019年03月06日 | 110.53% | 花旗集團 | $4.25→$2 | 維護 | 中性 |
What is the target price for Chimerix (CMRX)?
Chimerix(CMRX)的目標價是多少？
The latest price target for Chimerix (NASDAQ: CMRX) was reported by HC Wainwright & Co. on August 16, 2023. The analyst firm set a price target for $11.00 expecting CMRX to rise to within 12 months (a possible 1057.89% upside). 6 analyst firms have reported ratings in the last year.
納斯達克(JD：CMRX)的最新目標價是由HC Wainwright&Co.於2023年8月16日報道的。這家分析公司將目標價定為11美元，預計CMRX將在12個月內升至(可能上漲1057.89)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Chimerix (CMRX)?
Chimerix(CMRX)的最新分析師評級是多少？
The latest analyst rating for Chimerix (NASDAQ: CMRX) was provided by HC Wainwright & Co., and Chimerix reiterated their buy rating.
分析師對奇美力士(納斯達克代碼：CMRX)的最新評級由HC Wainwright&Co.提供，奇美力士重申其買入評級。
When is the next analyst rating going to be posted or updated for Chimerix (CMRX)?
Chimerix(CMRX)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chimerix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chimerix was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Chimerix的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Chimerix的上一次評級是在2023年8月16日提交的，所以你應該預計下一次評級將在2024年8月16日左右提供。
Is the Analyst Rating Chimerix (CMRX) correct?
分析師評級Chimerix(CMRX)正確嗎？
While ratings are subjective and will change, the latest Chimerix (CMRX) rating was a reiterated with a price target of $11.00 to $11.00. The current price Chimerix (CMRX) is trading at is $0.95, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Chimerix(CMRX)評級被重申，目標價在11.00美元至11.00美元之間。Chimerix(CMRX)目前的交易價格為0.95美元，超出了分析師的預測區間。